About this FactMed analysis covering adverse side effect reports of ALMARL patients who developed MYALGIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ALMARL reported MYALGIA to the FDA. A total of 227 ALMARL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALMARL and MYALGIA. In doing so, we compare ALMARL with other drugs that cause MYALGIA, to help you evaluate whether or not ALMARL causes MYALGIA. Likewise, this page shows the most highly-reported side effects of ALMARL, so you can see if MYALGIA ranks among ALMARL's most well-known side effects.
Summary Statistics
Reports of ALMARL causing MYALGIA: 1
Reports of any side effect of ALMARL : 227
Percentage of ALMARL patients where MYALGIA is a reported side effect: 0.4405%

FDA reports of any drug causing MYALGIA : 49594
Average percentage for all medicated patients where MYALGIA is reported as a complication: 0.3108%

Physician opinion on ALMARL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALMARL:
HYPERTENSION ( 76 patients )
PARKINSON'S DISEASE ( 8 patients )
ESSENTIAL TREMOR ( 6 patients )
ATRIAL FIBRILLATION ( 4 patients )
SCHIZOPHRENIA ( 2 patients )
TREMOR ( 2 patients )
ANGINA PECTORIS ( 2 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2 patients )
PALPITATIONS ( 2 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
TACHYCARDIA ( 2 patients )
HYPERTROPHY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with MYALGIA:

LIPITOR (6687 patients)
ASPIRIN (4311 patients)
CRESTOR (4284 patients)
FOSAMAX (3629 patients)
ZOCOR (2441 patients)
SIMVASTATIN (2294 patients)
SYNTHROID (1805 patients)
ATENOLOL (1626 patients)
FORTEO (1607 patients)
LISINOPRIL (1563 patients)
ACCUTANE (1557 patients)
VIOXX (1554 patients)
ZETIA (1541 patients)
LYRICA (1457 patients)
PREDNISONE (1436 patients)
HUMIRA (1416 patients)
NEXIUM (1415 patients)
PLAVIX (1273 patients)
REMICADE (1263 patients)
ZOMETA (1254 patients)
OMEPRAZOLE (1204 patients)
LEVAQUIN (1189 patients)
NIASPAN (1180 patients)
LASIX (1121 patients)
HYDROCHLOROTHIAZIDE (1069 patients)
VITAMIN D (1063 patients)
NEURONTIN (1028 patients)
RECLAST (996 patients)
ENBREL (977 patients)
XANAX (967 patients)
LEVOTHYROXINE SODIUM (958 patients)
NORVASC (951 patients)
BONIVA (950 patients)
CALCIUM (932 patients)
FOLIC ACID (927 patients)
AVONEX (925 patients)
PRILOSEC (914 patients)
FUROSEMIDE (898 patients)
TOPROL-XL (873 patients)
CELEBREX (853 patients)
ACETAMINOPHEN (848 patients)
METHOTREXATE (834 patients)
COUMADIN (824 patients)
ZOLOFT (817 patients)
SEROQUEL (805 patients)
IBUPROFEN (795 patients)
AMBIEN (775 patients)
DIOVAN (750 patients)
ALBUTEROL (741 patients)
PREVACID (739 patients)
METFORMIN HCL (714 patients)
VYTORIN (710 patients)
CYMBALTA (680 patients)
CHANTIX (656 patients)
TYSABRI (650 patients)
PROTONIX (645 patients)
VICODIN (644 patients)
AMLODIPINE (642 patients)
PAXIL (639 patients)
FISH OIL (637 patients)
ALLOPURINOL (636 patients)
SINGULAIR (633 patients)
LEXAPRO (613 patients)
AREDIA (604 patients)
GABAPENTIN (599 patients)
ACTONEL (599 patients)
PERCOCET (579 patients)
ATORVASTATIN CALCIUM (568 patients)
GLEEVEC (565 patients)
ADVAIR DISKUS 100/50 (564 patients)
LORAZEPAM (561 patients)
METOPROLOL TARTRATE (558 patients)
ATIVAN (553 patients)
PREDNISONE TAB (548 patients)
PREMARIN (542 patients)
OXYCONTIN (540 patients)
POTASSIUM CHLORIDE (533 patients)
MULTI-VITAMINS (529 patients)
PRAVACHOL (527 patients)
TRICOR (523 patients)
PREDNISOLONE (514 patients)
PEGASYS (512 patients)
MULTI-VITAMIN (510 patients)
CLONAZEPAM (507 patients)
ALLEGRA (506 patients)
ZYRTEC (492 patients)
RAMIPRIL (490 patients)
LANTUS (490 patients)
MAGNEVIST (485 patients)
PROZAC (480 patients)
DIAZEPAM (478 patients)
COZAAR (475 patients)
METOPROLOL (473 patients)
EFFEXOR (470 patients)
SIMCOR (470 patients)
VITAMIN E (469 patients)
DEXAMETHASONE (467 patients)
REBIF (461 patients)
TRAMADOL HCL (455 patients)
INSULIN (454 patients)
PRAVASTATIN (449 patients)
ALENDRONATE SODIUM (445 patients)
ALPRAZOLAM (443 patients)
DIGOXIN (435 patients)
WARFARIN SODIUM (425 patients)
WELLBUTRIN (422 patients)
KLONOPIN (419 patients)
ASCORBIC ACID (418 patients)
CIPROFLOXACIN (415 patients)
DURAGESIC-100 (413 patients)
FLEXERIL (413 patients)
ARIMIDEX (411 patients)
SPIRIVA (404 patients)
LEVOXYL (402 patients)
LAMICTAL (399 patients)
ALTACE (394 patients)
GLUCOPHAGE (393 patients)
ACTOS (388 patients)
OXYCODONE HCL (388 patients)
ZANTAC (386 patients)
ACETYLSALICYLIC ACID (384 patients)
METFORMIN (382 patients)
ACETYLSALICYLIC ACID SRT (378 patients)
COREG (378 patients)
TYLENOL (374 patients)
AMOXICILLIN (367 patients)
SANDOSTATIN LAR (367 patients)
AVELOX (363 patients)
RIBAVIRIN (363 patients)
LANSOPRAZOLE (351 patients)
NITROGLYCERIN (351 patients)
CALCIUM CARBONATE (350 patients)
TRAZODONE HCL (343 patients)
XOLAIR (338 patients)
VALIUM (337 patients)
VITAMIN B-12 (337 patients)
ELAVIL (336 patients)
RANITIDINE (331 patients)
ACLASTA (330 patients)
CELEXA (328 patients)
FEMARA (326 patients)
FLONASE (326 patients)
EXJADE (324 patients)
CIPRO (323 patients)
BENADRYL (320 patients)
BYETTA (319 patients)
ZOFRAN (317 patients)
PROLIA (313 patients)
COPEGUS (312 patients)
CYCLOSPORINE (308 patients)
ZITHROMAX (307 patients)
DECADRON (307 patients)
HEPARIN SODIUM INJECTION (307 patients)
FOSAMAX PLUS D (304 patients)
REVLIMID (303 patients)
EFFEXOR XR (303 patients)
PEG-INTRON (301 patients)
BACTRIM (299 patients)
TYLENOL (CAPLET) (297 patients)
MORPHINE (291 patients)
CIALIS (288 patients)
NAPROXEN (287 patients)
TRILIPIX (287 patients)
ACYCLOVIR (285 patients)
CYCLOPHOSPHAMIDE (284 patients)
LOVASTATIN (281 patients)
LORTAB (281 patients)
CLARITIN (280 patients)
GLIPIZIDE (277 patients)
TAXOTERE (275 patients)
AMLODIPINE BESYLATE (274 patients)
SPIRONOLACTONE (272 patients)
PEPCID (272 patients)
VALTREX (271 patients)
VITAMINS (270 patients)
LOVAZA (268 patients)
EPOGEN (268 patients)
ATORVASTATIN (268 patients)
PROMETHAZINE (267 patients)
ACIPHEX (265 patients)
JANUVIA (264 patients)
CLARITHROMYCIN (263 patients)
VITAMINS (UNSPECIFIED) (260 patients)
FENOFIBRATE (259 patients)
GLYBURIDE (259 patients)
CITALOPRAM HYDROBROMIDE (259 patients)
VERAPAMIL (259 patients)
GEMFIBROZIL (255 patients)
BACLOFEN (254 patients)
[THERAPY UNSPECIFIED] (252 patients)
CARVEDILOL (252 patients)
TOPAMAX (252 patients)
FLOMAX (249 patients)
HYDROCODONE BITARTRATE (249 patients)
TAMOXIFEN CITRATE (247 patients)
BENICAR (247 patients)
AMITRIPTYLINE HCL (246 patients)
BETASERON (245 patients)
HUMALOG (245 patients)
CLONIDINE (245 patients)
SOLIRIS (244 patients)
AVANDIA (243 patients)
GLUCOSAMINE (241 patients)
MICARDIS (241 patients)
TEGRETOL (240 patients)
METOPROLOL SUCCINATE (240 patients)
COLACE (239 patients)
CLINDAMYCIN (238 patients)
TASIGNA (236 patients)
ULTRAM (235 patients)
Most common side effects for patients taking ALMARL:
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
HALLUCINATION (15 patients)
FALL (13 patients)
HYPOGLYCAEMIA (13 patients)
PYREXIA (12 patients)
TREMOR (12 patients)
DIARRHOEA (11 patients)
HEPATIC FUNCTION ABNORMAL (11 patients)
PNEUMONIA (10 patients)
DYSARTHRIA (10 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (9 patients)
RENAL FAILURE ACUTE (9 patients)
LIVER DISORDER (9 patients)
CEREBRAL INFARCTION (8 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (8 patients)
DRUG INEFFECTIVE (8 patients)
RENAL IMPAIRMENT (8 patients)
HYPONATRAEMIA (8 patients)
INTERSTITIAL LUNG DISEASE (8 patients)
JAUNDICE (8 patients)
OEDEMA PERIPHERAL (8 patients)
CONDITION AGGRAVATED (7 patients)
DELIRIUM (7 patients)
DYSPHAGIA (7 patients)
DYSPNOEA (7 patients)
HYPOAESTHESIA (7 patients)
RHABDOMYOLYSIS (7 patients)
VOMITING (6 patients)
DELUSION (6 patients)
RESPIRATORY FAILURE (6 patients)
DYSKINESIA (6 patients)
SOMNOLENCE (6 patients)
HEPATIC NEOPLASM MALIGNANT (6 patients)
HYPERGLYCAEMIA (6 patients)
HYPOKALAEMIA (6 patients)
MOVEMENT DISORDER (6 patients)
MUSCULAR WEAKNESS (6 patients)
WHITE BLOOD CELL COUNT INCREASED (5 patients)
BLADDER CANCER (5 patients)
BLOOD ANTIDIURETIC HORMONE INCREASED (5 patients)
RESTLESSNESS (5 patients)
BLOOD OSMOLARITY DECREASED (5 patients)
PLEURAL EFFUSION (5 patients)
C-REACTIVE PROTEIN INCREASED (5 patients)
CONVULSION (5 patients)
RENAL DISORDER (5 patients)
VITH NERVE PARALYSIS (5 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (5 patients)
INTESTINAL OBSTRUCTION (5 patients)
SEPSIS (5 patients)
ROAD TRAFFIC ACCIDENT (5 patients)
MUSCULOSKELETAL PAIN (5 patients)
NAUSEA (5 patients)
ANOREXIA (4 patients)
ATELECTASIS (4 patients)
ATRIAL FIBRILLATION (4 patients)
ATRIOVENTRICULAR BLOCK (4 patients)
BLOOD CREATININE INCREASED (4 patients)
BRADYCARDIA (4 patients)
CARDIAC FAILURE (4 patients)
CONSTIPATION (4 patients)
DECREASED APPETITE (4 patients)
DEHYDRATION (4 patients)
DIZZINESS (4 patients)
PLATELET COUNT DECREASED (4 patients)
PAIN (4 patients)
HYPERTENSION (4 patients)
HYPOTHYROIDISM (4 patients)
ILEUS (4 patients)
METABOLIC ACIDOSIS (4 patients)
SMALL INTESTINE CARCINOMA (4 patients)
URINE OSMOLARITY INCREASED (4 patients)
ABASIA (3 patients)
AGGRESSION (3 patients)
PRURITUS (3 patients)
ANAEMIA (3 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (3 patients)
WHITE BLOOD CELL COUNT DECREASED (3 patients)
ASTHMA (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
RENAL FAILURE (3 patients)
BLOOD PRESSURE DECREASED (3 patients)
BLOOD PRESSURE INCREASED (3 patients)
VASCULITIS (3 patients)
CAROTID ARTERY STENOSIS (3 patients)
THERAPEUTIC AGENT TOXICITY (3 patients)
CHILLS (3 patients)
CHROMATURIA (3 patients)
PETECHIAE (3 patients)
CHRONIC LYMPHOCYTIC LEUKAEMIA (3 patients)
PORIOMANIA (3 patients)
RENAL ARTERY STENOSIS (3 patients)
PANCYTOPENIA (3 patients)
DRUG ERUPTION (3 patients)
SUDDEN ONSET OF SLEEP (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
VERTIGO (3 patients)
EPILEPSY (3 patients)
FACE OEDEMA (3 patients)
VOLVULUS (3 patients)
GENERALISED OEDEMA (3 patients)
GINGIVAL BLEEDING (3 patients)
HAEMORRHAGE SUBCUTANEOUS (3 patients)
HALLUCINATION, VISUAL (3 patients)
PSYCHIATRIC SYMPTOM (3 patients)
HEART RATE DECREASED (3 patients)
HELICOBACTER TEST POSITIVE (3 patients)
HEPATITIS FULMINANT (3 patients)
HYPERKALAEMIA (3 patients)
HYPOTENSION (3 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (3 patients)
LOSS OF CONSCIOUSNESS (3 patients)
SENSORY DISTURBANCE (3 patients)
LYMPHOMA (3 patients)
MALAISE (3 patients)
MARKEDLY REDUCED DIETARY INTAKE (3 patients)
RENAL TUBULAR DISORDER (3 patients)
NEOPLASM MALIGNANT (3 patients)
SINUS ARREST (3 patients)
ABDOMINAL DISCOMFORT (2 patients)
ABDOMINAL PAIN (2 patients)
ACUTE MYELOID LEUKAEMIA (2 patients)
STOMACH MASS (2 patients)
PERSONALITY CHANGE (2 patients)
AGITATION (2 patients)
ALTERED STATE OF CONSCIOUSNESS (2 patients)
ANAPHYLACTOID REACTION (2 patients)
ANGER (2 patients)
PRODUCTIVE COUGH (2 patients)
RENAL CYST (2 patients)
APHASIA (2 patients)
ASTHENIA (2 patients)
ATRIOVENTRICULAR BLOCK COMPLETE (2 patients)
THIRST (2 patients)
PROSTATE CANCER (2 patients)
BLOOD AMYLASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BODY TEMPERATURE INCREASED (2 patients)
SPEECH DISORDER (2 patients)
TUMOUR LYSIS SYNDROME (2 patients)
CEREBRAL HAEMORRHAGE (2 patients)
CHEST X-RAY ABNORMAL (2 patients)
COLON CANCER (2 patients)
COMA HEPATIC (2 patients)
COMPLETED SUICIDE (2 patients)
CONTUSION (2 patients)
PERFORMANCE STATUS DECREASED (2 patients)
DEFAECATION URGENCY (2 patients)
DEMENTIA ALZHEIMER'S TYPE (2 patients)
RASH PRURITIC (2 patients)
DIABETIC KETOACIDOSIS (2 patients)
DRUG INTERACTION (2 patients)
DRUG LEVEL INCREASED (2 patients)
DYSPEPSIA (2 patients)
DYSSTASIA (2 patients)
ELECTROCARDIOGRAM QT PROLONGED (2 patients)
STEVENS-JOHNSON SYNDROME (2 patients)
EPULIS (2 patients)
EXTRAOCULAR MUSCLE PARESIS (2 patients)
FACIAL PARESIS (2 patients)
FEAR (2 patients)
FEBRILE NEUTROPENIA (2 patients)
FEMORAL NECK FRACTURE (2 patients)
FOOT FRACTURE (2 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (2 patients)
GANGRENE (2 patients)
GASTRIC ULCER HAEMORRHAGE (2 patients)
GINGIVAL HYPERTROPHY (2 patients)
GLOSSOPTOSIS (2 patients)
PLEURISY (2 patients)
PHRENIC NERVE PARALYSIS (2 patients)
HAEMATEMESIS (2 patients)
HAEMATURIA (2 patients)
HAEMOGLOBIN DECREASED (2 patients)
POLLAKIURIA (2 patients)
ORAL INTAKE REDUCED (2 patients)
HEPATIC CYST (2 patients)
HEPATIC ENCEPHALOPATHY (2 patients)
HEPATITIS (2 patients)
HYPERREFLEXIA (2 patients)
HYPERTONIA (2 patients)
HYPERURICAEMIA (2 patients)
RASH PAPULAR (2 patients)
INITIAL INSOMNIA (2 patients)
RETINAL OEDEMA (2 patients)
INTESTINAL FUNCTIONAL DISORDER (2 patients)
RESPIRATION ABNORMAL (2 patients)
IRRITABILITY (2 patients)
RIB FRACTURE (2 patients)
LEG AMPUTATION (2 patients)
LYMPHADENOPATHY (2 patients)
METABOLIC ALKALOSIS (2 patients)
ORAL HERPES (2 patients)
TAKAYASU'S ARTERITIS (2 patients)
MOUTH HAEMORRHAGE (2 patients)
UNRESPONSIVE TO STIMULI (2 patients)
TOXIC SKIN ERUPTION (2 patients)
NEPHROLITHIASIS (2 patients)
SUICIDE ATTEMPT (2 patients)
VENTRICULAR FIBRILLATION (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
UPPER RESPIRATORY TRACT INFECTION (2 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (2 patients)
SHOCK HAEMORRHAGIC (2 patients)
ABDOMEN CRUSHING (1 patients)
CARDIAC FAILURE CONGESTIVE (1 patients)
EOSINOPHILIC PNEUMONIA ACUTE (1 patients)
ESSENTIAL TREMOR (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)
FUNGAL INFECTION (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALMARL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about MYALGIA and ALMARL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALMARL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALMARL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALMARL experts. If you are a healthcare provider experienced in prescribing ALMARL, please register here.

Your online appointment book for Vernal Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use